PRICE T ROWE ASSOCIATES INC /MD/ – Vertex Pharmaceuticals Incorporated Transaction History
PRICE T ROWE ASSOCIATES INC /MD/ portfolio value:
$1.49B
portfolio value
PRICE T ROWE ASSOCIATES INC /MD/ quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.93% | 195.27K shares | 95.02M | $289.54 | 5.15M |
| Q2 2022 | share | Decrease | -6.45% | -342.01K shares | 14.06M | $281.79 | 4.96M |
| Q1 2022 | share | Decrease | -2.15% | -116.59K shares | 193.85M | $260.97 | 5.30M |
| Q4 2021 | share | Decrease | -4.86% | -276.95K shares | 156.91M | $222.45 | 5.42M |
| Q3 2021 | share | Decrease | -56.50% | -7.40M shares | -1.60B | $181.39 | 5.69M |
| Q2 2021 | share | Decrease | -20.85% | -3.45M shares | -915.35M | $201.63 | 13.09M |
| Q1 2021 | share | Decrease | -15.68% | -3.07M shares | -1.07B | $214.89 | 16.54M |
| Q4 2020 | share | Decrease | -3.65% | -744K shares | -910.55M | $236.34 | 19.62M |
| Q3 2020 | share | Decrease | -3.90% | -827.57K shares | -610.80M | $272.12 | 20.37M |
| Q2 2020 | share | Decrease | -1.97% | -425.40K shares | 1.00B | $290.31 | 21.19M |
| Q1 2020 | share | Decrease | -11.83% | -2.90M shares | -224.53M | $237.95 | 21.62M |
| Q4 2019 | share | Decrease | -6.71% | -1.76M shares | 915.87M | $218.95 | 24.52M |
| Q3 2019 | share | Increase | +5.64% | 1.40M shares | -109.50M | $169.42 | 26.29M |
| Q2 2019 | share | Decrease | -4.82% | -1.26M shares | -246.10M | $183.38 | 24.88M |
| Q1 2019 | share | Increase | +1.54% | 397.23K shares | 542.74M | $183.95 | 26.14M |
| Q4 2018 | share | Increase | +2.72% | 682.80K shares | -564.40M | $165.71 | 25.74M |
| Q3 2018 | share | Decrease | -2.25% | -577.05K shares | 472.94M | $192.74 | 25.06M |
| Q2 2018 | share | Decrease | -6.98% | -1.92M shares | -134.74M | $169.96 | 25.64M |
| Q1 2018 | share | Decrease | -2.72% | -770.18K shares | 246.28M | $162.98 | 27.56M |
| Q4 2017 | share | Increase | +7.03% | 1.86M shares | 221.03M | $149.86 | 28.33M |
| Q3 2017 | share | Increase | +7.71% | 1.89M shares | 857.78M | $152.04 | 26.47M |
| Q2 2017 | share | Increase | +6.98% | 1.60M shares | 655.32M | $128.87 | 24.58M |
| Q1 2017 | share | Increase | +5.12% | 1.11M shares | 902.26M | $109.35 | 22.97M |
| Q4 2016 | share | Decrease | -6.91% | -1.62M shares | -437.53M | $73.67 | 21.86M |
| Q3 2016 | share | Increase | +1.01% | 235.52K shares | 48.20M | $87.21 | 23.48M |
| Q2 2016 | share | Decrease | -7.04% | -1.76M shares | 11.85M | $86.02 | 23.24M |
| Q1 2016 | share | Increase | +32.86% | 6.18M shares | -380.63M | $79.49 | 25.00M |